Form 8-K - Current report:
SEC Accession No. 0001493152-24-000192
Filing Date
2024-01-03
Accepted
2024-01-03 08:00:37
Documents
15
Period of Report
2023-12-28
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52076
2 ex99.htm EX-99 10858
3 ex99_001.jpg GRAPHIC 4076
  Complete submission text file 0001493152-24-000192.txt   299985

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20231228.xsd EX-101.SCH 3944
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20231228_def.xml EX-101.DEF 27404
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20231228_lab.xml EX-101.LAB 37859
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20231228_pre.xml EX-101.PRE 26021
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6228
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 24504386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)